Social and financial barriers to optimum tki treatment in patients with chronic myeloid leukemia- a knowledge-attitudes-practices study from india
Conclusion: Cost of treatment, lack of widespread availability of hematology services and poor patient awareness are significant barriers to optimum treatment of CML in low and middle income countries.
Source: Mediterranean Journal of Hematology and Infectious Diseases - Category: Hematology Authors: Naveen Gupta, Manoranjan Mahapatra, Tulika Seth, Seema Tyagi, Sudha Sazawal, Renu Saxena Source Type: research
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Gleevec | Hematology | India Health | Infectious Diseases | Leukemia | Study